Star Health and Allied Insurance Company IPO GMP History
Star Health and Allied Insurance Company IPO has been listed on December 10, 2021 at a listing price of ₹845, against the issue price of ₹900 — a loss of ₹55 (-6.11%). The GMP peaked at ₹120 on 24 November 2021 and reached a low of ₹80 on 25 November 2021. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Star Health and Allied Insurance Company IPO raised ₹6018.68 Cr. through its IPO at a price band of ₹870 to ₹900 per share, with a lot size of 16 shares. The IPO was open for subscription from 30 Nov 2021 to 02 Dec 2021.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 7:27 AM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 25 Nov 2021 | ₹ 80 | ▼ | 9% | — | — |
| 24 Nov 2021 | ₹ 120 | — | 13% | — | — |
Star Health and Allied Insurance Company IPO dates
Key dates from opening to listing. Today is 10 November.
- Open 30 Nov 2021
- Close 02 Dec 2021
- Allotment 07 Dec 2021
- Refund/credit 08 Dec 2021
- Listing 10 Dec 2021
Star Health and Allied Insurance Company IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹900 |
|---|---|
| GMP-based estimate (pre-listing) | ₹980 (+8.9%) |
| Listing gain / loss | −₹55 per share |
| Listing date | 10 Dec, 2021 |
| Actual listing price | ₹845 (-6.11%) |
Is Star Health and Allied Insurance Company IPO GMP reliable?
Grey market premium for Star Health and Allied Insurance Company IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Star Health and Allied Insurance Company IPO full review for a fundamentals-based assessment before making any grey market trades.
Star Health and Allied Insurance Company IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Star Health and Allied Insurance Company IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Star Health and Allied Insurance Company IPO
Star Health and Allied Insurance Company Limited was incorporated at Chennai on 17 June 2005. It was the first standalone health insurance company in India, established in 2006, and has grown into the largest one.
In Fiscal 2021 it had total gross written premium of Rs 93,489.50 million and insured 20.5 million lives. Retail health gave 89.3% of health GWP and group health 10.7%.
It sells mainly through individual agents, plus corporate agent banks and other corporate agents. It had 779 health insurance branches across 25 states and 5 union territories, and a network of more than 11,778 hospitals.
The IPO was Rs 6,018.68 crore, with Rs 2,000.66 crore of fresh issue and Rs 4,018.03 crore of offer for sale. The fresh money was meant to strengthen the capital base. The promoters are Safecrop Investments India LLP, Rakesh Jhunjhunwala and WestBridge AIF I.
Frequently asked
What is the GMP of Star Health and Allied Insurance Company IPO?
The current Grey Market Premium (GMP) of Star Health and Allied Insurance Company IPO is ₹ 80.
What is the Kostak Price of Star Health and Allied Insurance Company IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Star Health and Allied Insurance Company IPO is not available.
What is the Subject to Sauda Price of Star Health and Allied Insurance Company IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Star Health and Allied Insurance Company IPO?
Star Health and Allied Insurance Company IPO listed on December 10, 2021 at ₹845, against the issue price of ₹900 — a loss of -6.11%.
How did the GMP of Star Health and Allied Insurance Company IPO trend before listing?
The GMP of Star Health and Allied Insurance Company IPO was falling in its final days before listing. The GMP peaked at ₹120 on 24 November 2021. View the day-wise table above for the complete GMP history.
Explore Star Health and Allied Insurance Company IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
